Get the Stockscreener App
1.01
4.72%
-0.05
Assertio Holdings Inc stock is traded at $1.01, with a volume of 347.26K.
It is down -4.72% in the last 24 hours and down -11.40% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$1.06
Open:
$1.06
24h Volume:
347.26K
Relative Volume:
0.66
Market Cap:
$96.29M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
0.6824
EPS:
1.48
Net Cash Flow:
$70.07M
1W Performance:
-8.18%
1M Performance:
-11.40%
6M Performance:
-1.94%
1Y Performance:
-56.84%
1-Day Range:
$0.9952
$1.07
1-Week Range:
$0.9952
$1.1076
52-Week Range:
$0.7324
$2.37
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio (ASRT) Set to Announce Quarterly Earnings on Monday - MarketBeat
ASRTAssertio Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 - The Manila Times
Non-Steroidal Anti-Inflammatory Drugs Market Sees Robust Growth Amid Rising Demand | PLC, and Assertio - EIN News
Director Vacirca Jeff L acquire 10,000 shares of Assertio Holdings Inc [ASRT] - Knox Daily
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - GlobeNewswire
A closer look at Assertio Holdings Inc (ASRT)’s stock price trends - US Post News
Assertio Holdings, Inc. (NASDAQ:ASRT) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
AQR Capital Management LLC Decreases Stock Holdings in Assertio Holdings, Inc. (NASDAQ:ASRT) - MarketBeat
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
ASRT Stock Sees Decline of Approximately -5.08% in Last Five Days - Knox Daily
Trading Day Triumph: Assertio Holdings Inc (ASRT) Ends at 1.12, a -2.61 Surge/Plunge - The Dwinnex
Assertio Holdings Inc Inc. (ASRT) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
ASOS PLC Reports Major Stake Acquired by SIH PARTNERS - TipRanks
Assertio Holdings Inc (ASRT) requires closer examination - US Post News
Metric Deep Dive: Understanding Assertio Holdings Inc (ASRT) Through its Ratios - The Dwinnex
Is Assertio Holdings (NASDAQ:ASRT) Using Debt Sensibly? - Simply Wall St
ASTRAZENECA PHARMA Share Price Today Down 5% - Equitymaster
Insider Selling: Asana, Inc. (NYSE:ASAN) COO Sells 29,807 Shares of Stock - Defense World
Manuel Alba Sells 37,000 Shares of Astera Labs, Inc. (NASDAQ:ALAB) Stock - Defense World
Astera Labs director sells over $5 million in company stock By Investing.com - Investing.com Canada
Magnetar Financial LLC Buys Shares of 20,305 Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Views of Wall Street’s Leading Experts on Astera Labs Inc. - SETE News
Form 8.3ASCENTIAL PLC - ShareCast
Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by Logos Global Management LP - MarketBeat
Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by American Century Companies Inc. - Defense World
Astec Lifesciences: Brokerage revises stock's rating post CEO exitDetails - ET Now
Will Astera Labs Inc. (ALAB) meet earnings estimates this quarter? - US Post News
Assurant price target raised to $224 from $217 at UBS - TipRanks
Investing in Assertio Holdings Inc (ASRT): What You Must Know - Knox Daily
Discovery Capital Management LLC CT Reduces Stake in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Rhumbline Advisers Takes $1.01 Million Position in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Astera Labs, Inc. (NASDAQ:ALAB) Shares Bought by Massachusetts Financial Services Co. MA - Defense World
Victory Capital Management Inc. Invests $815,000 in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Seven Eight Capital LP Invests $994,000 in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Astera Labs (NASDAQ:ALAB) Trading 3.8% Higher - Defense World
Stocks of Assertio Holdings Inc (ASRT) are poised to climb above their peers - SETE News
Astera Labs executive sells over $3.4 million in stock - Investing.com
A stock that deserves closer examination: Assertio Holdings Inc (ASRT) - US Post News
Analyzing Ratios: Assertio Holdings Inc (ASRT)’s Financial Story Unveiled - The Dwinnex
Assertio Holdings Inc [ASRT] Insider Activity: An Update for Investors - Knox Daily
Assertio Holdings, Inc. (NASDAQ:ASRT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Assertio Holdings Inc (ASRT) receives a Buy rating from Maxim Group - Knox Daily
Assertio Holdings: Management Change Could Improve Comeback Chances (NASDAQ:ASRT) - Seeking Alpha
Assertio Holdings Inc’s latest rating changes from various analysts - Knox Daily
Assertio Holdings, Inc. (NASDAQ:ASRT) Forecasted to Post FY2025 Earnings of $0.08 Per Share - MarketBeat
How to interpret Assertio Holdings Inc (ASRT)’s stock chart patterns - US Post News
Q1 2025 EPS Estimates for Assertio Holdings, Inc. Decreased by Analyst (NASDAQ:ASRT) - MarketBeat
Assertio Holdings Inc (ASRT) Stock: A Year of Market Fluctuations - The InvestChronicle
Assertio Holdings Inc [ASRT] Shares Fall Approximately -62.73% Over the Year - Knox Daily
Analgesics MarketMajor Technology Giants in Buzz Again | - openPR
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assertio Holdings Inc Stock (ASRT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Vacirca Jeff L | Director |
Jun 11 '24 |
Buy |
1.11 |
10,000 |
11,100 |
151,159 |
| Mason Heather L | Interim Executive Officer |
Jun 05 '24 |
Buy |
0.97 |
25,000 |
24,250 |
212,650 |
| Schlessinger Sam | SVP, General Counsel |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
138,895 |
| Schwichtenberg Paul | SVP, CCO |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
141,941 |
| Patel Ajay | SVP and CFO |
May 12 '24 |
Option Exercise |
0.00 |
38,017 |
0 |
171,271 |
| Tyree James L | Director |
Mar 14 '24 |
Sale |
1.12 |
10,251 |
11,463 |
188,251 |
| Schlessinger Sam | SVP, General Counsel |
Feb 21 '24 |
Option Exercise |
0.00 |
17,151 |
0 |
109,384 |
| Schwichtenberg Paul | SVP, CCO |
Feb 21 '24 |
Option Exercise |
0.00 |
17,151 |
0 |
112,430 |
| Patel Ajay | SVP and CFO |
Feb 21 '24 |
Option Exercise |
0.00 |
17,151 |
0 |
141,760 |
| Schlessinger Sam | SVP, General Counsel |
Feb 11 '24 |
Option Exercise |
0.00 |
18,939 |
0 |
98,785 |
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):